ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE | N209381 | SALIX PHARMACEUTICALS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
BAUSCH HEALTH IRELAND LIMITED et al v. LUPIN LTD. et al 6 patentsANDA 212934polyethylene glycol 3350 (140 g), sodium ascorbate (48.11 g), sodium sulfate (9 g), ascorbic acid (7.54 g), sodium chloride (5.2 g), and potassium chloride (2.2 g) | D.N.J. | 2020-08-21 | Terminated 2021-03-30 | — |
Bausch Health Ireland Limited et al v. Lupin Ltd. et al 5 patentsANDA 212934polyethylene glycol 3350 (140 g), sodium ascorbate (48.11 g), sodium sulfate (9 g), ascorbic acid (7.54 g), sodium chloride (5.2 g), and potassium chloride (2.2 g) | D. Del. | 2019-04-03 | Terminated 2019-08-05 | — |
BAUSCH HEALTH IRELAND LIMITED et al v. LUPIN INC. 5 patentsANDA 212934polyethylene glycol 3350 (140 g), sodium ascorbate (48.11 g), sodium sulfate (9 g), ascorbic acid (7.54 g), sodium chloride (5.2 g), and potassium chloride (2.2 g) for oral solution | D.N.J. | 2019-04-01 | Terminated 2021-09-20 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8999313 | Sep 10, 2033 | — | — | Yes | — | — |
| 9326969 | Sep 10, 2033 | — | — | — | — | |
| 9592252 | Aug 11, 2032 | — | — | Yes | — | |
| 9707297 | Sep 10, 2033 | — | — | Yes | — | — |
| 10016504 | Sep 10, 2033 | — | — | Yes | — | — |
| 10646512 | Mar 25, 2032 | — | — | Yes | — | — |
| 10780112 | Mar 9, 2032 | — | — | Yes | — | — |
| 10792306 | Mar 9, 2032 | — | — | Yes | — | |
| 10918723 | Sep 10, 2033 | — | — | — | — | |
| 11529368 | Mar 9, 2032 | — | — | Yes | — | |
| 12083179 | Sep 10, 2033 | — | — | Yes | — |